1. Home
  2. KTTA vs ASNS Comparison

KTTA vs ASNS Comparison

Compare KTTA & ASNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KTTA
  • ASNS
  • Stock Information
  • Founded
  • KTTA 2020
  • ASNS 1998
  • Country
  • KTTA United States
  • ASNS United States
  • Employees
  • KTTA N/A
  • ASNS N/A
  • Industry
  • KTTA Biotechnology: Pharmaceutical Preparations
  • ASNS Telecommunications Equipment
  • Sector
  • KTTA Health Care
  • ASNS Telecommunications
  • Exchange
  • KTTA Nasdaq
  • ASNS Nasdaq
  • Market Cap
  • KTTA 5.1M
  • ASNS 5.5M
  • IPO Year
  • KTTA 2021
  • ASNS 2022
  • Fundamental
  • Price
  • KTTA $0.68
  • ASNS $0.62
  • Analyst Decision
  • KTTA
  • ASNS Strong Buy
  • Analyst Count
  • KTTA 0
  • ASNS 1
  • Target Price
  • KTTA N/A
  • ASNS $5.00
  • AVG Volume (30 Days)
  • KTTA 119.6K
  • ASNS 436.5K
  • Earning Date
  • KTTA 08-19-2025
  • ASNS 08-18-2025
  • Dividend Yield
  • KTTA N/A
  • ASNS N/A
  • EPS Growth
  • KTTA N/A
  • ASNS N/A
  • EPS
  • KTTA N/A
  • ASNS N/A
  • Revenue
  • KTTA N/A
  • ASNS $7,755,000.00
  • Revenue This Year
  • KTTA N/A
  • ASNS N/A
  • Revenue Next Year
  • KTTA N/A
  • ASNS $104.77
  • P/E Ratio
  • KTTA N/A
  • ASNS N/A
  • Revenue Growth
  • KTTA N/A
  • ASNS 72.95
  • 52 Week Low
  • KTTA $0.65
  • ASNS $0.45
  • 52 Week High
  • KTTA $7.50
  • ASNS $1.86
  • Technical
  • Relative Strength Index (RSI)
  • KTTA 38.79
  • ASNS 60.79
  • Support Level
  • KTTA $0.67
  • ASNS $0.51
  • Resistance Level
  • KTTA $0.79
  • ASNS $0.63
  • Average True Range (ATR)
  • KTTA 0.04
  • ASNS 0.05
  • MACD
  • KTTA 0.00
  • ASNS 0.01
  • Stochastic Oscillator
  • KTTA 23.70
  • ASNS 79.59

About KTTA Pasithea Therapeutics Corp.

Pasithea Therapeutics Corp is a biotechnology company. It is focused on the discovery, research, and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies and certain cancers. It leveraging in the fields of neuroscience, translational medicine, and drug development. Its pipeline includes Neurofibromatosis Type 1, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), and Schizophrenia. Companies pipelines includes PAS-004 (Macrocyclic Small Module[MEK1/2]), PAS-003 (Monoclonal antibody),PAS-001 (Small Module).

About ASNS Actelis Networks Inc.

Actelis Networks Inc is a networking solutions company with a mission to enable communication for Internet of Things, or IoT, projects, deployed over wide areas such as cities, campuses, airports, military bases, roads, and rail. Its networking solutions use a combination of newly deployed fiber infrastructure and existing copper and coaxial lines to create a cost-effective, secure, and quick-to-deploy network. Its solutions also offer end-to-end network security to protect critical IoT data, utilizing a powerful combination of coding and encryption technologies, applied as required on both new and existing infrastructure within the hybrid-fiber-copper network. The company operates as one operating segment: developing and marketing access broadband equipment for copper and fiber networks.

Share on Social Networks: